Ferreira 2019.

Methods	Single centre RCT enrolling adult recipients of ECD donors
Participants	171 enrolled
Interventions	All receive single dose of 1 gm methylprednisolone & then oral prednisone & induction with 4 doses of ATG Group 1 EVL from day 1 and TAC from day 8 Group 2 MPA from day 1 and TAC from day 8
Outcomes	The primary endpoint was the cumulative incidence of first CMV infection/disease during the first year after transplantation Other outcomes treatment failure, BPAR
Notes	The institution “Hospital do Rim” have received research grants from Novartis and Sanofi to conduct this study